Contact Information: Inquiries Press Sidonie Myers Head of Communication Smith & Nephew Advanced Wound Management +44 (0) 1482 673246 Investors and Analysts Phil Cowdy Director Investor Relations Smith & Nephew +44 (0) 20 7401 7646
Smith & Nephew Announces the Global Launch of New ALLEVYN* Ag Gentle and ALLEVYN Ag Gentle Border Antimicrobial Dressings
| Source: Smith & Nephew PLC
HULL, UK--(Marketwire - September 16, 2009) - Smith & Nephew's (LSE : SN ) (NYSE : SNN ) Advanced
Wound Management division, announced today that it is launching two
extensions to the ALLEVYN Ag range of dressings; ALLEVYN Ag Gentle Border
and ALLEVYN Ag Gentle. These dressings will combine the antimicrobial
protection of silver with the gentleness of silicone and soft gel adhesives
that have been specifically designed to minimise pain to the patient and
trauma to the wound at dressing removal.
These two new exciting ALLEVYN Ag variants are available in a range of
sizes and offer patients living with a wound and clinicians three key
benefits: antimicrobial protection to help fight infection; minimal pain on
removal at dressing change and superior fluid management thanks to the
unique triple action technology of ALLEVYN.
Roger Teasdale, President, Smith & Nephew Advanced Wound Management, said,
"The addition of these two new ALLEVYN Ag variants will undoubtedly add to
the growing success of ALLEVYN and will enable us to maintain our position
as the leading global brand within the foam dressings market. ALLEVYN Ag
Gentle Border provides the perfect opportunity to reinforce the perception
of Smith & Nephew as leading the way in woundcare as we will be the first
company to offer an adhesive bordered silicone silver product which
combines the benefits of silver and silicone gel technology. I am pleased
that we have been able to enhance the ALLEVYN Ag range in a way which
offers additional benefits and choice to our customers and which will
continue to improve the quality of life for patients living with a wound."
It was encouraging to note that these new additions were enthusiastically
greeted by US clinicians following their recent launch: "An innovative new
dressing which provides antimicrobial protection, as well as the ability to
remove and re-apply without disruption of the wound base, which is suitable
for many types of wounds especially skin tears" Paula Kotz, BSN, RN, C,
CWOCN, E.T. Consultant Services Inc., Asheville, NC.
The launch of ALLEVYN Ag Gentle and ALLEVYN Ag Gentle Border means that we
now offer a complete range of foam dressings for infected as well as non
infected wounds and are in the unique position of being able to provide a
clinically proven and cost effective solution for all customers foam
dressing needs.
For more information regarding Smith & Nephew, please visit our Web site
at http://www.smith-nephew.com
About Smith & Nephew
Smith & Nephew is a global medical technology business, specializing in
Orthopaedics, including Reconstruction, Trauma and Clinical Therapies,
Endoscopy and Advanced Wound Management. Smith & Nephew is a global leader
in arthroscopy and advanced wound management and is one of the leading
global orthopaedics companies.
Smith & Nephew is dedicated to helping improve people's lives. The Company
prides itself on the strength of its relationships with its surgeons and
professional healthcare customers, with whom its name is synonymous with
high standards of performance, innovation and trust. The Company operates
in 32 countries around the world. Annual sales in 2008 were nearly $3.8
billion.
Forward-Looking Statements
This press release contains certain "forward-looking statements" within the
meaning of the US Private Securities Litigation Reform Act of 1995. In
particular, statements regarding expected revenue growth and trading
margins discussed under "Outlook" are forward-looking statements as are
discussions of our product pipeline. These statements, as well as the
phrases "aim," "plan," "intend," "anticipate," "well-placed," "believe,"
"estimate," "expect," "target," "consider" and similar expressions, are
generally intended to identify forward-looking statements. Such
forward-looking statements involve known and unknown risks, uncertainties
and other important factors (including, but not limited to, the outcome of
litigation, claims and regulatory approvals) that could cause the actual
results, performance or achievements of Smith & Nephew, or industry
results, to differ materially from any future results, performance or
achievements expressed or implied by such forward-looking statements.
Please refer to the documents that Smith & Nephew has filed with the U.S.
Securities and Exchange Commission under the U.S. Securities Exchange Act
of 1934, as amended, including Smith & Nephew's most recent annual report
on Form 20F, for a discussion of certain of these factors.
All forward-looking statements in this press release are based on
information available to Smith & Nephew as of the date hereof. All written
or oral forward-looking statements attributable to Smith & Nephew or any
person acting on behalf of Smith & Nephew are expressly qualified in their
entirety by the foregoing. Smith & Nephew does not undertake any obligation
to update or revise any forward-looking statement contained herein to
reflect any change in Smith & Nephew's expectation with regard thereto or
any change in events, conditions or circumstances on which any such
statement is based.
*Trademark of Smith & Nephew